Published

State health care committee continues to press pharmaceutical middlemen

Summary by Shaw Local
State legislators resumed a series of hearings this week to scrutinize pharmacy benefit managers – a highly concentrated industry that critics say drives up the cost and limits availability of prescription drugs.PBMs, which have also faced scrutiny from the federal government, act as third-party “middlemen” who negotiate which drugs health insurance companies and pharmacies can purchase. By creating formularies, or catalogs of the specific drugs…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.